IDNA holdings — iShares Genomics Immunology and Healthcare ETF
iShares Genomics Immunology and Healthcare ETF (IDNA) held 61 positions with net assets of $191M as of July 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 49.5% of the fund, led by BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares, Bayer Aktiengesellschaft, TWST.
IDNA top holdings
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39% ($19.8M)
- Bayer Aktiengesellschaft — 4.81% ($9.18M)
- TWST Twist Bioscience Corp — 4.79% ($9.15M)
- RVMD REVOLUTION MEDICINES, INC. — 4.55% ($8.69M)
- REGN REGENERON PHARMACEUTICALS, INC. — 4.35% ($8.30M)
- GENMAB A/S — 4.23% ($8.08M)
- INCY INCYTE CORPORATION — 4.23% ($8.08M)
- MRNA MODERNA, INC. — 4.19% ($7.99M)
- Takeda Pharmaceutical Company Limited — 4.05% ($7.73M)
- MRK MERCK & CO., INC. — 3.91% ($7.46M)
- VRTX VERTEX PHARMACEUTICALS INCORPORATED — 3.87% ($7.39M)
- Roche Holding AG — 3.85% ($7.34M)
- IPSEN SA — 3.84% ($7.33M)
- BNTX BioNTech SE — 3.73% ($7.11M)
- EXEL EXELIXIS, INC. — 3.65% ($6.96M)
- GSK PLC — 3.63% ($6.93M)
- SANOFI SA — 3.46% ($6.61M)
- IDYA IDEAYA Biosciences Inc — 3.36% ($6.41M)
- IBRX Immunitybio Inc — 3.07% ($5.86M)
- RCUS ARCUS BIOSCIENCES, INC. — 2.68% ($5.12M)
- CAI CARIS LIFE SCIENCES, INC. — 2.18% ($4.17M)
- ONO PHARMACEUTICAL CO., LTD. — 1.91% ($3.65M)
- IOVA Iovance Biotherapeutics Inc — 1.80% ($3.43M)
- NUVB NUVATION BIO INC. — 1.78% ($3.39M)
- CRSP CRISPR Therapeutics AG — 1.57% ($2.99M)
What are IDNA's top 10 holdings?
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares (10.4%), Bayer Aktiengesellschaft (4.8%), TWST (4.8%), RVMD (4.6%), REGN (4.4%), GENMAB A/S (4.2%), INCY (4.2%), MRNA (4.2%), Takeda Pharmaceutical Company Limited (4.0%), MRK (3.9%).
How many stocks are in IDNA?
iShares Genomics Immunology and Healthcare ETF reported 61 holdings as of July 31, 2026.